These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10658620)

  • 1. Intrasubthalamic nucleus metabotropic glutamate receptor activation: a behavioral, Fos immunohistochemical and [14C]2-deoxyglucose autoradiographic study.
    Kearney JA; Albin RL
    Neuroscience; 2000; 95(2):409-16. PubMed ID: 10658620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabotropic glutamate agonist-induced rotation: a pharmacological, FOS immunohistochemical, and [14C]-2-deoxyglucose autoradiographic study.
    Kearney JA; Frey KA; Albin RL
    J Neurosci; 1997 Jun; 17(11):4415-25. PubMed ID: 9151758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of nigrostriatal dopamine in metabotropic glutamate agonist-induced rotation.
    Kearney JA; Becker JB; Frey KA; Albin RL
    Neuroscience; 1998 Dec; 87(4):881-91. PubMed ID: 9759976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrastriatal and intrasubthalamic stimulation of metabotropic glutamate receptors: a behavioral and Fos immunohistochemical study.
    Kaatz KW; Albin RL
    Neuroscience; 1995 May; 66(1):55-65. PubMed ID: 7637875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of mGluR glutamate receptors in the subthalamic nucleus ameliorates motor asymmetry in an animal model of Parkinson's disease.
    Phillips JM; Lam HA; Ackerson LC; Maidment NT
    Eur J Neurosci; 2006 Jan; 23(1):151-60. PubMed ID: 16420425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity.
    Lopez S; Jouve L; Turle-Lorenzo N; Kerkerian-Legoff L; Salin P; Amalric M
    Neurobiol Dis; 2012 Apr; 46(1):69-77. PubMed ID: 22245662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: behavioral and histological analyses.
    Agari T; Yasuhara T; Matsui T; Kuramoto S; Kondo A; Miyoshi Y; Shingo T; Borlongan CV; Date I
    Brain Res; 2008 Apr; 1203():189-96. PubMed ID: 18313647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
    Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
    Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mGluRs: a target for pharmacotherapy in Parkinson disease.
    Feeley Kearney JA; Albin RL
    Exp Neurol; 2003 Nov; 184 Suppl 1():S30-6. PubMed ID: 14597323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
    Turner MS; Gray TS; Mickiewicz AL; Napier TC
    Brain Struct Funct; 2008 Sep; 213(1-2):197-213. PubMed ID: 18663473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective blockade of serotonin 2C receptor enhances Fos expression specifically in the striatum and the subthalamic nucleus within the basal ganglia.
    De Deurwaerdère P; Le Moine C; Chesselet MF
    Neurosci Lett; 2010 Jan; 469(2):251-5. PubMed ID: 20004702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat.
    Salin P; Manrique C; Forni C; Kerkerian-Le Goff L
    J Neurosci; 2002 Jun; 22(12):5137-48. PubMed ID: 12077209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.
    Awad H; Hubert GW; Smith Y; Levey AI; Conn PJ
    J Neurosci; 2000 Nov; 20(21):7871-9. PubMed ID: 11050106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of striatal group II metabotropic glutamate receptors has a differential effect on dopamine-D1 and -D2 receptor antagonist-induced hypokinesia in the rat.
    Kronthaler UO; Schmidt WJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):289-97. PubMed ID: 10731042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-frequency electrical stimulation of the subthalamic nucleus excites target structures in a model using c-fos immunohistochemistry.
    Shehab S; D'souza C; Ljubisavljevic M; Redgrave P
    Neuroscience; 2014 Jun; 270():212-25. PubMed ID: 24755486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of blockade of metabotropic glutamate receptors in the subthalamic nucleus on haloperidol-induced Parkinsonism in rats.
    Miwa H; Nishi K; Fuwa T; Mizuno Y
    Neurosci Lett; 2000 Mar; 282(1-2):21-4. PubMed ID: 10713387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent.
    Cobb WS; Abercrombie ED
    Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata.
    Bradley SR; Marino MJ; Wittmann M; Rouse ST; Awad H; Levey AI; Conn PJ
    J Neurosci; 2000 May; 20(9):3085-94. PubMed ID: 10777772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.